Globimetula braunii prevents hyperglycemia, oxidative damage, and hepatorenal dysfunction in dexamethasone-induced insulin-resistant rats

Globimetula braunii prevents hyperglycemia, oxidative damage, and hepatorenal dysfunction in dexamethasone-induced insulin-resistant rats

Introduction: Globimetula braunii is a parasitic plant used in Cameroon in traditional medicine to treat diabetes mellitus. The present work aimed to evaluate the protective effects of aqueous leaf extract of G. braunii (EGB) on rats rendered insulin-resistant by dexamethasone. Methods: To induce in...

Full description

Saved in:

Bibliographic Details
Main Authors:	David Miaffo, Kilenma Kolefer, Elizé Dadaya, Barthelemy Maidadi, Abba Talba Mahamad, Albert Kamanyi
Format:	Article
Language:	English
Published:	Shahrekord University of Medical Sciences 2024-12-01
Series:	Journal of HerbMed Pharmacology
Subjects:	dexamethasone globimetula braunii hepatorenal markers insulin-resistance oxidative stress
Online Access:	https://herbmedpharmacol.com/PDF/jhp-14-43.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Acute and subacute toxicity of the aqueous extract of Cissus Polyantha Glig and Bradt (Vitaceae) on biochemical and hematological parameters in Wistar rats
by: David Miaffo, et al.
Published: (2025-07-01)

Influence of Ultrasonic Cavitation on Botryococcus Braunii Growth
by: Asleena SALAEH
Published: (2024-06-01)

Therapeutic Potential of Fractions of <i>Globimetula oreophila</i> (Oliv. ex Hook.f.) Leaf Extract Growing on <i>Azadirachta indica</i> against <i>Plasmodium berghei</i>-Infected Mice: An In Vivo Approach
by: Dauda Garba, et al.
Published: (2024-05-01)

Environmental emission analysis of the engine using Botryococcus braunii marine algae with CeO2 nanoparticle additives
by: S. Karthikeyan, et al.
Published: (2023-12-01)

Phytochemical Constituents from <i>Globimetula oreophila</i> as Plasmepsin I and II Inhibitors in Antimalarial Drug Discovery: An In Silico Approach
by: Dauda Garba, et al.
Published: (2024-11-01)

Features of the course of hepatorenal syndrome in decompensated portal hypertension (case report)
by: M.I. Tutchenko, et al.
Published: (2024-06-01)

Diosgenin mitigates oxidative stress and inflammation within the hepatorenal system associated with epilepsy and alcohol use disorders in murine models
by: Emmanuel O. Chidebe, et al.
Published: (2025-08-01)

CLINICAL EFFICACY OF ALBUMIN DIALYSIS THERAPY FOR PATIENTS WITH HEPATORENAL SYNDROME
by: D. E. Kutepov, et al.
Published: (2009-06-01)

Treatment of hepatorenal syndrome
by: Kezić Aleksandra, et al.
Published: (2007-01-01)

Hepatorenal bypass as a salvage strategy after occlusion following branched endovascular aortic repair
by: Tainá Curado Gomes de Barros, MD, et al.
Published: (2025-06-01)

Ameliorative Effects of Nettle (Urtica dioica) Seed Extract on Methotrexate-Induced Hepatorenal Damage in Rats
by: Ahmet Uyar, et al.
Published: (2025-06-01)

An Update on Hepatorenal Syndrome
by: Samuel Chan, et al.
Published: (2017-03-01)

Hepatorenal syndrome: a Nationwide Trend Analysis from 2008 to 2018
by: Jagmeet Singh, et al.
Published: (2021-01-01)

Systemic reviews and meta-analysis of the use of midodrine in hepatorenal syndrome
by: Prem Balaji Reddy Lankapothu, et al.
Published: (2024-09-01)

Pathophysiological Significance of Urea in Glomerular Filtration Dysregulation in Hepatorenal Syndrome: An Integrative Review
by: Anatoliy Gozhenko, et al.
Published: (2025-08-01)

Hepatorenal protective effects of essential oils against chemical overexposure induced oxidative damage
by: Faming Jiang, et al.
Published: (2025-04-01)

Zonula occludens 1 as a novel biomarker in decompensated alcoholic cirrhosis with hepatorenal syndrome
by: Balasubramaniyan Vairappan, et al.
Published: (2025-05-01)

Effects of the aqueous extract from Abelmoschus esculentus L peel on hyperglycemia and hyperlipidemia induced by dexamethasone in rats
by: Aisha Dugani, et al.
Published: (2018-01-01)

Chemotherapeutic efficacy of curcumin against plasma and cardio-hepatorenal electrolyte disruption in dichlorvos-challenged rats via augmentation of Na⁺/K⁺-ATPase and Ca²⁺/Mg²⁺-ATPase activities
by: Adio J. Akamo, et al.
Published: (2025-06-01)

Readmission Rate, Predictors, Outcomes, and Burden of Readmission of Hepatorenal Syndrome in the United States: A Nationwide Analysis
by: Abdullah Sohail, et al.
Published: (2024-11-01)

Hepatorenal protection of food supplement (Prosopis africana) in rat following metal mixture exposure via alternations in oxido-inflammatory markers
by: Harrison A. Ozoani, et al.
Published: (2025-05-01)

Diagnostical significance of dimethylarginine in the development of hepatorenal syndrome in patients with alcoholic liver cirrhosis
by: Ničković Vanja, et al.
Published: (2012-01-01)

Nostoc commune Vauch. polysaccharide alleviates Pb-induced hepatorenal toxicity by changing gut bacteriome, mycobiome, and metabolome
by: Yue Liu, et al.
Published: (2024-11-01)

The protective effect of various forms of Nigella sativa against hepatorenal dysfunction: underlying mechanisms comprise antioxidation, anti- inflammation, and anti-apoptosis
by: Reham M. Algheshairy, et al.
Published: (2025-05-01)

Thymoquinone mitigates diclofenac-induced hepatorenal toxicity in male Wistar rats by balancing the redox state and modulating Bax/Bcl-2/caspase-3 apoptotic pathways and NF-κB signaling
by: Amir Safi, et al.
Published: (2025-01-01)

The effect of organic extracts on the microelements content in selected species of forage grasses
by: Milena Truba, et al.
Published: (2024-12-01)

PATHOLOGICAL EFFECT OF DEXAMETHASONE ON HEALING OF RABBIT WOUND
by: Aula Essmial H, et al.
Published: (2010-06-01)

Dexamethasone, dexamethasone + remdesivir in treating moderate to severe COVID-19: retrospective observational cohort study
by: Nithish Sattoju, et al.
Published: (2023-07-01)

Hepatorenal syndrome misdiagnosis may be reduced using inferior vena cava ultrasound to assess intravascular volume and guide management
by: Elaine M. Kaptein, et al.
Published: (2023-12-01)

STUDY EFFECT THE DEXAMETHASONE FOR LONG TERM IN EYE RABBITS
by: Rana K. Abdulsamad
Published: (2015-12-01)

EFFECT OF DEXAMETHASONE ON LIVER FUNCTION IN MALE RATS EXPOSED TO PARAQUAT
by: Rana A. Asim Man S. Kalo Soulaf J. Kakel
Published: (2012-12-01)

Assessment of an integrated therapeutic protocol for sheep with acute ruminal impaction: diagnostic and prognostic significance of rumen functions and hepatorenal biomarkers
by: Enas Elmeligy, et al.
Published: (2025-05-01)

Development and validation of a machine learning-based prediction model for hepatorenal syndrome in liver cirrhosis patients using MIMIC-IV and eICU databases
by: Fengwei Yao, et al.
Published: (2025-01-01)

Efficacy of Contezolid in the Treatment of Catheter-Related Bloodstream Infections Caused by Methicillin-Resistant Staphylococcus aureus in a Patient with Hepatorenal Syndrome and Acute Kidney Injury: A Case Report
by: Zhang X, et al.
Published: (2025-01-01)

Renal recovery following orthotopic liver transplant after prolonged kidney injury: Perspectives on diagnosing hepatorenal syndrome and determining which patients should undergo simultaneous liver kidney transplantation
by: Mary Elizabeth Card, et al.
Published: (2017-07-01)

Antihypertensive effect of allicin in dexamethasone-induced hypertensive rats
by: Harikesh Dubey, et al.
Published: (2017-03-01)

Hepatorenal Syndrome: direct treatment costs and characteristics of patients admitted to intensive care
by: Franciele Robes Hortelã, et al.
Published: (2025-04-01)

Development of Spectrophotometric method for quantitative determination of dexamethasone in pharmaceutical preparations
by: Rafal Abdulraheem Abdullah, et al.
Published: (2023-01-01)

Dexamethasone in anesthesia practice: A narrative review
by: Teena Bansal, et al.
Published: (2024-01-01)

A comparative study of prophylactic nebulized dexamethasone versus intravenous dexamethasone for prevention of postoperative sore throat in prone-position surgeries
by: Sarayu Ramamurthy, et al.
Published: (2024-08-01)